Success of Digital Pathology May Come Through its Ability to Handle Volumes
Digital and computational pathology expert Donal O’Shea explores the role of emerging technologies in addressing workforce shortages
Author Information
Michael Schubert, PhD
Michael Schubert, PhD, is a veteran science and medicine communicator. He holds graduate degrees in biochemistry and molecular biology with a research focus on chromatin structure and function and has written on subjects from subspeciality pathology to fictional science. In addition to writing and editing, he is co-director of the Digital Communications Fellowship in Pathology and Course Trainer at the Lightyear Foundation, an initiative aimed at making science accessible to all.
Posts by the Author
Reimbursing Genetic Counselors in the Clinical Lab
Sara Pirzadeh-Miller offers advice on overcoming the reimbursement barriers genetic counselors face in the clinical lab and beyond
CMS-lcaEssentialFee Schedules-lirFunding-lirLab Industry AdvisorReimbursement-lirMichael Schubert, PhD
Change and Constancy: The 2025 CLFS Update
The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025
Patients at the Point of Care
At-home testing is giving patients an increasingly active role in managing their health—but what does this trend mean for labs?
Choosing and Using Wisely
The value of lab test utilization management—and the ASCP’s latest best practice recommendations for effective test utilization
CLIA-lcaCMS-lcaCompliance Perspectives-lcaCompliance-lcaEssentialLab Industry AdvisorLegislation-lcaMichael Schubert, PhD
Compliance Concerns: Laboratory Regulations in 2024 and Beyond
Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025
Staffing: 2024’s Biggest Lab Operations Challenge
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Digital Pathology and AI: Now and in 2025
Experts Nathan Buchbinder and Julianna Ianni discuss digital pathology and AI trends in 2024—and what the next year may hold
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
A Lasting Impact: COVID-19 and Cancer Screening
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
